Pfizer Limited (PFIZER.BO)
Pfizer Limited operates in the Drug Manufacturers - General industry of the Healthcare sector, headquartered in Mumbai, MA, IN. The stock last traded at $4879.25, down 2.11% on the session, giving a market capitalisation of $223.28B. Its beta of 0.08 implies it has historically moved less than the broad market.
Pfizer Limited, an Indian pharmaceutical powerhouse, actively produces, promotes, distributes, and exports a diverse range of medicinal products across both domestic Indian markets and international territories. Its comprehensive portfolio spans numerous therapeutic domains, addressing needs in areas such as neuro/central nervous system disorders, hormonal imbalances, cardiovascular health, hemophilia, infectious diseases, gynecology, pain management, orthopedics, oncology, urology, anti-parasitic treatments, gastrointestinal issues, vaccines, respiratory conditions, and essential vitamins/minerals/nutrients. The firm channels its offerings to consumers via an extensive network of independent distributors, primarily marketing them under established brand names. Established in 1950, the company's central operations are located in Mumbai, India.
Pfizer Limited is most often compared with the following Healthcare names: